177 related articles for article (PubMed ID: 214608)
1. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
Mortensen RF
J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
[No Abstract] [Full Text] [Related]
2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. I. Cell requirements, specificity, lack of H-2 restriction, and role of antibody.
Mortensen RF; Elson LM
J Immunol; 1980 May; 124(5):2316-23. PubMed ID: 6154099
[No Abstract] [Full Text] [Related]
5. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
Plata F; Jongeneel CV
J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
[No Abstract] [Full Text] [Related]
6. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
Basombrío MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
7. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
Law LW; Ting RC
J Natl Cancer Inst; 1970 Mar; 44(3):615-21. PubMed ID: 11515430
[No Abstract] [Full Text] [Related]
8. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
Enjuanes L; Lee JC; Ihle JN
J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
[No Abstract] [Full Text] [Related]
9. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immune reactions directed against syngeneic methylcholanthrene-induced mouse sarcomas: low reproducibility of the results obtained with the tube modification of leukocyte adherence inhibition assay.
Simová J; Bubeník J
Neoplasma; 1979; 26(5):635-9. PubMed ID: 392326
[TBL] [Abstract][Full Text] [Related]
11. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
Takeichi N; Austin FC; Oikawa T; Boone CW
Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
[TBL] [Abstract][Full Text] [Related]
12. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
Basombrio MA
Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
[No Abstract] [Full Text] [Related]
13. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
Kalafut F; Hung PM; Novotná L; Grófová M
Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
[TBL] [Abstract][Full Text] [Related]
14. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
Pazmiño NH; Yuhas JM
Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
[No Abstract] [Full Text] [Related]
15. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.
Halliday WJ
J Immunol; 1971 Mar; 106(3):855-7. PubMed ID: 5547301
[No Abstract] [Full Text] [Related]
16. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
17. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
Gomard E; Duprez V; Henin Y; Levy JP
J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
[TBL] [Abstract][Full Text] [Related]
18. [Studies on column fractionation of immune cells. 3. Tumor neutralization test].
Eckert R; Pasternak G
Acta Biol Med Ger; 1973; 31(2):305-10. PubMed ID: 4544039
[No Abstract] [Full Text] [Related]
19. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
20. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
